In an interview to CNBC-TV18, Amritanshu Khaitan, MD of Eveready India spoke about the results and his outlook for the company. The company is in the process of implementing certain price hikes in AA and AAA categories to mitigate the cost pressure which has impacted margins in Q4, he said.
first published: May 31, 2017 12:31 pm
A collection of the most-viewed Moneycontrol videos.

New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live

Nifty Trades in a Narrow 100-Point Range on 2025’s Final F&O Expiry | Closing Bell Live

Small-Caps & Risk: What Investors Often Miss

Nifty’s Best Case Target & Top Stock Bets For 2026| IPO Wave Set To Get Bigger| Opening Bell Live
You are already a Moneycontrol Pro user.

